文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

黑色素瘤全脑放疗随机试验中海马保护的质量保证分析显示依从性良好

Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
PubMed 文献 · Radiat Oncol · 2018-07-20

该研究评估WBRT-Mel随机试验中海马保护全脑放疗(HA-WBRT)的质量保证,按RTOG-0933标准回顾性分析22例患者剂量学数据,18例(82%)在约束范围内,4例(18%)仅单侧海马出现不可接受偏差。

要点

  • 22例接受HA-WBRT的患者中,18例(82%)符合RTOG-0933剂量学约束。
  • 4例(18%)仅单侧海马出现不可接受偏差,所有患者至少单侧海马满足约束。
  • 最常见方案为30 Gy分10次,占91%。

核心结论

  • 该剂量学质量保证研究显示,按RTOG-0933剂量学约束标准依从性良好(82%),所有患者至少单侧海马满足RTOG海马保护约束。

研究设计与样本

  • 研究为WBRT-Mel随机III期试验(NCT01503827)中的剂量学质量保证分析,2009年4月至2017年9月共入组215例,107例随机至WBRT组,22例在4个中心接受HA-WBRT。
  • 18例在同一中心治疗,中位年龄65岁,剂量学数据回顾性提取并按RTOG-0933约束标准分析。

主要发现

  • 22例HA-WBRT患者中,18例(82%)按RTOG-0933标准在约束范围内,4例(18%)仅单侧海马出现不可接受偏差。
  • 最常见HA-WBRT方案为30 Gy分10次,占91%。
  • HA-WBRT前,10例仅接受手术,6例仅接受放射外科,4例接受手术和放射外科,2例仅接受与HA-WBRT同步的同步推量。
  • 20例计划保护双侧海马,2例因MBM靠近一侧海马而计划保护对侧海马。

关键数值与推荐

  • RTOG-0933研究剂量学约束标准:18例(82%)在约束范围内,4例(18%)仅单侧海马不可接受偏差。
  • 所有患者至少单侧海马满足RTOG海马保护约束。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Melanoma brain metastases (MBM) often cause morbidity and mortality for stage IV melanoma patients. An ongoing randomised phase III trial (NCT01503827 - WBRT-Mel) evaluates the role of adjuvant whole brain radiotherapy (WBRT) following local treatment of MBM. Hippocampal avoidance during WBRT (HA-WBRT) has shown memory and neurocognitive function (NCF) preservation in the RTOG-0933 phase II study. This study assessed the quality assurance of HA-WBRT within the WBRT-Mel trial according to RTOG-0933 study criteria. METHODS: Hippocampal avoidance was allowed in approved centres with intensity-modulated radiotherapy capability. Patients treated by HA-WBRT were not randomized within the WBRT arm. The RTOG 0933 contouring Atlas was used to contour hippocampi. In the trial co-ordinating centre, patients were treated with volumetric modulated arc therapy using complementary arcs; similar techniques were used at other sites. Dosimetric data were extracted retrospectively and analysed in accordance with RTOG 0933 study constraints criteria. RESULTS: Among the 215 patients accrued to the WBRT-Mel study between April 2009 and September 2017, 107 were randomized to the WBRT arm, 22 were treated by HA-WBRT in 4 centers. Eighteen patients were treated in the same centre. The median age was 65 years. The commonest (91%) HA-WBRT schema was 30 Gy in 10 fractions. Prior to HA-WBRT, 10 patients had been treated by surgery alone, six by radiosurgery alone, four by surgery and radiosurgery and two exclusively by simultaneous integrated boost concurrent to HA-WBRT. Twenty patients were treated with intention to spare both hippocampi and two patients had MBM close to one hippocampus and were treated with intention to spare the contralateral hippocampus. According to RTOG-0933 study criteria, 18 patients (82%) were treated within constraints and four patients (18%) had unacceptable deviation in just one hippocampus. CONCLUSIONS: This dosimetric quality assurance study shows good compliance (82%) according to RTOG-0933 study dosimetric constraints. Indeed, all patients respected RTOG hippocampal avoidance constraints on at least one hippocampus. In the futureanalysis of the WBRT-Mel trial, the NCF of patients on the observation arm, WBRT arm and with HA-WBRT arm will be compared.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Martinage G, Hong AM, Fay M, et al. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance. Radiat Oncol. 2018. PMID: 30029684. doi:10.1186/s13014-018-1077-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。